Company: ELV
Filing Date: 2025-04-22
Form Type: 10-Q
Source: 0001156039-25-000057
Chunk: 90

Company: Elevance Health, Inc.
Filing Date: 2025-04-22
Form: 10-Q
Item: Item 2
Chunk 90
---
, proceeds from business divestitures, proceeds from borrowings and proceeds from the issuance of common stock under our employee stock plans. Cash disbursements result mainly from claims payments, operating expenses, taxes, purchases of investment securities, interest expense, payments on borrowings, acquisitions, capital expenditures, repurchases of our debt securities and common stock and the payment of cash dividends. 

-45-

Cash outflows fluctuate with the amount and timing of settlement of these transactions. Any future decline in our profitability would likely have an unfavorable impact on our liquidity.

For a more detailed overview of our liquidity and capital resources management, see the “Introduction” section included in the “Liquidity and Capital Resources” section of Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2024 Annual Report on Form 10-K.

For additional information regarding our sources and uses of capital during the three months ended March 31, 2025, see Note 5, “Investments,” Note 6, “Derivative Financial Instruments,” Note 10, “Debt,” and Note 12, “Capital Stock – Use of Capital – Dividends and Stock Repurchase Program,” of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Liquidity

A summary of our major sources and uses of cash and cash equivalents for the three months ended March 31, 2025 and 2024 is as follows:

 Three Months Ended  March 31 20252024ChangeSources of Cash:Net cash provided by operating activities$1,017 $1,978 $(961)Issuances of short- and long-term debt, net of repayments— 1,350 (1,350)Proceeds from sales, maturities, calls and redemptions of investments, net of purchases610 — 610 Proceeds from issuance of common stock under employee stock plans23 97 (74)Changes in bank overdrafts546 546 Total sources of cash2,196 3,425 (1,229)Uses of Cash:Purchases of investments, net of proceeds from sales, maturities, calls and redemptions— (670)670 Purchases of subsidiaries, net of cash acquired— (1,120)1,120 Repurchase and retirement of common stock(880)(566)(314)Purchases of property